Entra Pharma Raises $4.2M

Luke Timmerman12/18/08

Entra Pharmaceuticals, a Waltham, MA-based drug delivery startup, raised $4.2 million in the first tranche of a Series A venture financing, according to PE Hub, which cited a regulatory filing. The round could be expanded to $12.5 million by the end of November if Entra reaches certain milestones. Flybridge Capital Partners and North Bridge Venture Partners are backing the company.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.